By employing different phase autophagy regulators and Cav-1 siRNA and pcDNA3.1 plasmid, we verified that the therapeutic efficacy of BMSC-sEVs on BBB integrity was Caveolin-1-dependent autophagic degradation of ZO-1 and Occludin after ischemic stroke. This evidence concerns the gene CAV1 and ischemic stroke.